إعلان
إعلان
STOK
Stoke Therapeutics, Inc. Common Stock
32.85
USDبرعاية
-0.83
-2.45%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
33.03
+0.18
+0.55%
تقارير أرباح STOK
النسبة الإيجابية المفاجئة
STOK تفوق 17 من 26 آخر التقديرات.
65%
التقرير التالي
بيانات التقرير القادم
١٦ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$5.95M
/-$0.73
التغير الضمني من Q3 25 (Revenue/ EPS)
-44.04%
/+12.31%
التغير الضمني من Q4 24 (Revenue/ EPS)
-73.69%
/+305.56%
Stoke Therapeutics, Inc. Common Stock earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, STOK reported earnings of -0.65 USD per share (EPS) for Q3 25, missing the estimate of -0.57 USD, resulting in a -12.13% surprise. Revenue reached 10.63 مليون, compared to an expected 6.28 مليون, with a 69.21% difference. The market reacted with a -9.94% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 المحللين forecast an EPS of -0.73 USD, with revenue projected to reach 5.95 مليون USD, implying an زيادة of 12.31% EPS, and نقصان of -44.04% in Revenue from the last quarter.
الأسئلة الشائعة
What were Stoke Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Stoke Therapeutics, Inc. Common Stock reported EPS of -$0.65, missing estimates by -12.13%, and revenue of $10.63M, 69.21% above expectations.
How did the market react to Stoke Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -9.94%, changed from $25.34 before the earnings release to $22.82 the day after.
When is Stoke Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٦ مارس ٢٠٢٦.
What are the forecasts for Stoke Therapeutics, Inc. Common Stock's next earnings report?
Based on 13
المحللين, Stoke Therapeutics, Inc. Common Stock is expected to report EPS of -$0.73 and revenue of $5.95M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان